Barely Significant
← all excerpts

Developing an NT3-loaded exosomal biodegradable conductive hydrogel combined with EA for targeted treatment of spinal cord injury.

Mater Today Bio · 2025 · PMC12213280 · PMID 40605987

1
hedged sentence
closest p
boldest claim

The sentences

showed a trendno p-value reported
The treatment using Exo-N combined with NT3@ICH nanoparticles (Exo-N/NT3@ICH) showed a trend toward recovering neuronal cell viability and promoting neuroregeneration. 3.5 In vitro validation of Exo-N/NT3@ICH as a therapeutic approach against oxidative stress and inflammation in neuronal cells The material implemented in the study was further validated in vitro using the verification analyses, which supported the therapeutic application of the materials.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.